welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Surgical Prophylaxis in Familial Adenomatous Polyposis: Do Pre-Existing Desmoids Outside the Abdominal Cavity Matter?
source: Familial cancer
year: 2010
authors: Sinha A, Gibbons D C, Phillips R K, Clark S
summary/abstract:Desmoid tumours (DT) are myofibroblastic proliferations found in 10-25% of familial adenomatous polyposis (FAP) patients, either intra-abdominally (IA), in the abdominal wall (AW) or elsewhere (extra-abdominal (EA)). Most DT occur following prophylactic colectomy but occasionally patients present with pre-operative DT. Mutations 3′ to codon 1444, predispose to DT and attenuated phenotype, leading to a potential strategy of delaying surgery in patients at high risk of DT. Here we assess if the existence of a pre-operative AW-DT or EA-DT predisposes to IA-DT following laparotomy. Data were collected on FAP patients undergoing primary surgery at St Mark’s Hospital. Patients were stratified into those having no DT, EA-DT or AW-DT pre-operatively. Relative-risks were calculated and proportions compared using Fisher’s exact-test. 587 FAP patients were identified; nine discovered with IA-DT intra-operatively were excluded. 5(0.9%) and 6(1%) of the remainder had a pre-operative EA-DT and AW-DT, respectively; one (0.2%) had both. Six of these 12 developed a post-operative IA-DT. 566(98%) had no pre-operative DT, 50(9%) of these developed IA-DT post-operatively; median time to tumour was 2 (IQR, 1-3.5) years. A pre-operative AW-DT predisposed to IA-DT post-operatively (RR = 7.6, 95% CI 4.0-14.1, P = 0.0009) whilst EA-DT did not (RR = 2.3, 0.4-13.3, P = 0.38). A 3′ mutation was significantly associated with post-operative IA-DT in the ‘no pre-operative DT’ group (P = 0.002). The presence of a DT external to the abdominal cavity pre-operatively, poses a clinical challenge with regards to surgical decision-making. Patients with an AW-DT pre-operatively may warrant a conservative surgical approach, to minimize post-operative IA-DT risk.
organization: Imperial CollegeDOI: 10.1007/s10689-010-9342-9
read more full text source
expertly curated content related to this topic
-
Long-Term Treatment with Sulindac in Familial Adenomatous Polyposis: A Prospective Cohort StudyBACKGROUND & AIMS : Management of pa...
-
Rectal Epithelial Apoptosis does not Predict Response to Sulindac Treatment or Polyp Development in Presymptomatic F...Innormal colorectal epithelium, apoptosi...
-
Ask the Genetic CounselorThere is colorectal cancer in my family ...
-
Rectal Proliferation and Polyp Occurrence in Pateints with Familial Adenomatous Polyposis after Sulindac TreatmentBACKGROUND/AIMS : Sulindac, a nonsteroid...
-
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)The purpose of this phase III study is t...
-
ESMO Consensus Guidelines For Management of Patients with Colon and Rectal Cancer, A Personalized Approach to Clinic...Colorectal Cancer (CRC) is the most comm...
-
F.A.P. Surveillance Exams: What’s involved?https://www.youtube.com/watch?v=NPIsTBJf...